昊海生物科技(06826.HK)委任田敏為董事會祕書及聯席公司祕書
格隆匯12月19日丨昊海生物科技(06826.HK)發佈公告,黃明已由執行董事獲調任為非執行董事,自2019年12月19日起生效。黃明將自2019年12月19日起不再擔任董事會祕書,並將自2020年1月1日或公司收到香港聯交所有關新委任聯席公司祕書的豁免函件之日(以較晚者為準)起不再擔任公司聯席公司祕書。
此外,田敏將獲委任為董事會祕書及聯席公司祕書。田敏將自2019年12月19日起擔任董事會祕書。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.